Reply
Retina
.
2022 Oct 1;42(10):e50-e51.
doi: 10.1097/IAE.0000000000003575.
Authors
Paula Scholz
1
,
Lebriz Altay
1
,
Vasilena Sitnilska
1
,
Elon H C van Dijk
2
,
Alberto M Pereira
3
,
Femke M van Haalen
3
,
Isha Akhtar
4
,
Camiel J F Boon
2
5
,
Sascha Fauser
1
6
Affiliations
1
Department of Ophthalmology, University Hospital of Cologne, Cologne, Germany.
2
Department of Ophthalmology, Leiden University Medical Center, Leiden, Netherlands.
3
Department of Medicine, Division of Endocrinology, and Center for Endocrine Tumors, Leiden University Medical Center, Leiden, Netherlands.
4
Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.
5
Department of Ophthalmology, Academic Medical Center, Amsterdam, the Netherlands.
6
F. Hoffmann-La Roche, Basel, Switzerland.
PMID:
35921625
DOI:
10.1097/IAE.0000000000003575
No abstract available
Publication types
Letter
Comment